Fast Locator 2014-2015: AbbVie - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2014-2015: AbbVie


AbbVie
1401 Sheridan Rd
North Chicago, IL  60064

Regions served:
Globally located with plants in North America and Europe

Description:
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company¹s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world¹s most complex and serious diseases.  AbbVie Contract Manufacturing offers outsourcers access to a scientific team with a vast amount of knowledge and experience, and some of the world¹s most technically advanced facilities. 

Website
www.abbviecontractmfg.com

Services Provided:
AbbVie Contract Manufacturing
AbbVie continues a legacy of more than a century at the forefront of pharmaceutical development and manufacturing. For more than 25 years, the company has offered contract manufacturing services that today comprise biologics, potent, drug product, fermentation, prefilled syringe manufacturing and hot melt extrusion (HME), as well as selling high-quality active pharmaceutical ingredients (APIs).

The creation of AbbVie streamlined the business to solely drug development. Combining the focus of a biotech with the expertise of an established pharmaceutical leader, the contract manufacturing business is agile and flexible in its service to companies outsourcing the development and manufacture of drugs.

AbbVie Contract Manufacturing has a portfolio of 10 state-of-the-art facilities, offering a broad range of capabilities in North America and Europe. Clients are reliably served by a company with one of the industry's leading reputations for high-quality, on-time delivery. The company takes pride in its outstanding customer service record, with experienced planning and project management specialists dedicating specific time slots for contract manufacturing.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here